©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 107570
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.107570
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.107570
Table 1 Prespecified eligibility criteria
| Participants | Interventions | Comparison | Outcomes | Study types |
| Age > 18 years; acute stroke patients receiving intravenous thrombolytics | Intervention group: Telemedicine (audio and video) evaluation by neurology specialist | Control group: In-person evaluation by neurology specialist | Primary outcome: Door-to-needle time. Secondary outcomes: sICH; mortality; mRS ≤ 2; only studies evaluating one or more of these outcomes | RCT; observational cohort study |
- Citation: Loggini A, Schwertman A, Hornik J, Dallow K, Hornik A. Stroke metrics, safety, and outcomes of telemedicine-administered thrombolytics for acute ischemic stroke: A meta-analysis. World J Crit Care Med 2025; 14(4): 107570
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/107570.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.107570